- Home
- RAPP vs AMC Comparison
RAPP vs AMC Comparison
Compare RAPP & AMC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RAPP | AMC |
|---|---|---|
| Founded | 2022 | 1920 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Movies/Entertainment |
| Sector | | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.3B |
| IPO Year | 2024 | 2013 |
Fundamental Metrics
Financial Performance| Metric | RAPP | AMC |
|---|---|---|
| Price | $29.89 | $1.99 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 6 |
| Target Price | ★ $47.80 | $3.33 |
| AVG Volume (30 Days) | 368.1K | ★ 17.1M |
| Earning Date | 11-06-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $4,867,000,000.00 |
| Revenue This Year | N/A | $8.75 |
| Revenue Next Year | N/A | $8.01 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 9.74 |
| 52 Week Low | $6.43 | $2.05 |
| 52 Week High | $42.27 | $4.47 |
Technical Indicators
Market Signals| Indicator | RAPP | AMC |
|---|---|---|
| Relative Strength Index (RSI) | 59.79 | 29.49 |
| Support Level | $28.03 | $2.25 |
| Resistance Level | $31.00 | $2.34 |
| Average True Range (ATR) | 1.83 | 0.10 |
| MACD | 0.11 | -0.01 |
| Stochastic Oscillator | 72.79 | 1.02 |
Price Performance
Historical ComparisonAbout RAPP Rapport Therapeutics Inc.
Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucidated the complexities of neuronal receptor biology and enables the company to map and target certain neuronal receptor complexes. Neuronal receptors are complex assemblies of proteins, comprising receptor principal subunits and their receptor-associated proteins (RAPs), the latter of which play crucial roles in regulating receptor expression and function.
About AMC AMC Entertainment Holdings Inc.
AMC Entertainment Holdings Inc is involved in the theatrical exhibition business. It owns, operates, or has interests in theatres located in the United States and Europe. It provides amenities such as plush, power recliners, MacGuffins full bars, AMC Dine-In Theatres, and premium presentation. The company has identified two reportable segments and reporting units for its theatrical exhibition operations, U.S. markets and International markets. It derives key revenue from the U.S.